S5 - E21.5 - The Updated MASLD CPG: Implications For Healthcare Systems
Send us Fan Mail In this closing conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi and podcast co-hosts Louise Campbell and Roger Green consider what the guidelines might...
30 Jun 202412min
S5 - E21.4 - The Updated MASLD CPG: Pharmacology And New Educational Needs
Send us Fan Mail For most of this conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi discuss key issues related to pharmacology and prescribing choices. At the end, the fo...
30 Jun 202411min
S5 - E21.3 - The Updated MASLD CPG: Screening, Diagnosing And Managing Patients
Send us Fan Mail In this conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi discuss some of the guidelines' key goals and issues surrounding the screening, diagnosis and m...
29 Jun 202413min
S5 - E21.2 - The Updated MASLD CPG: Benefits Of The Collaboration
Send us Fan Mail In this conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi explain how the guidelines process benefitted from the close collaboration between EASL, EASD, ...
29 Jun 202411min
S5 - E21.1 - The Updated MASLD CPG: Introductions
Send us Fan Mail Two of the co-authors of the upgraded MASLD Clinical Practice Guidelines, Elisabetta Bugianesi and Frank Tacke join Louise Campbell and Roger Green to discuss the guidelines. The t...
29 Jun 20249min
S5 - E21 - Reviewing The Updated ESL-EASD-EASO MASLD Clinical Practice Guidelines
Send us Fan Mail 00:00:00 - Surf's Up: Season 5 Episode 21 One important session at the EASL Congress 2024 involved the presentation of the new MASLD Clinical Practice Guidelines. CPG co-authors Elis...
27 Jun 202452min
S5 - E20.6 - From the Vault: FGF-21s and "Twin-cretins" At EASL Congress 2023
Send us Fan Mail In this conversation from July 2023, Stephen Harrison, Jörn Schattenberg and Roger Green discuss the implications of presentations on the FGF-21 agent efruxifermin and the dual GLP/gl...
23 Jun 202414min
S5 - E20.5 - Drug Development Highlights From EASL Congress 2024: Denifenstat, SPECIAL and Other Stories
Send us Fan Mail Mazen Noureddin and Naim Alkhouri join Jörn Schattenberg and Roger Green to discuss some of the other major drug development stories from the EASL Congress 2024, with special focus on...
23 Jun 202413min
